Market Cap 211.52M
Revenue (ttm) 0.00
Net Income (ttm) -156.82M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio -0.74
Volume 802,100
Avg Vol 1,139,484
Day's Range N/A - N/A
Shares Out 58.59M
Stochastic %K 50%
Beta 2.16
Analysts Sell
Price Target $22.50

Company Profile

Omeros Corporation, a clinical-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule and protein therapeutics, and orphan indications targeting immunologic diseases. The company's lead products candidate is the Narsoplimab (OMS721/MASP-2) for the treatment of hematopoietic stem-cell transplant-associated thrombotic microangiopathy (TA-TMA); and in Phase II clinical trial to treat COVID-19 and acute respiratory distress syndrome. It also develops OMS1029 that has...

Industry: Biotechnology
Sector: Healthcare
Phone: 206 676 5000
Address:
The Omeros Building, 201 Elliott Avenue West, Seattle, United States
naturegirl669
naturegirl669 Jul. 17 at 6:11 AM
$OMER - Narsoplimab........what about the Asian market??????........any revs there, how soon??? While information on the Asian population specifically regarding HSCT-TMA is limited, studies suggest they are represented in research cohorts, and some data points to their incidence rates for both confirmed and suspected TMA cases. Research on outcomes in specific Asian subgroups, such as the Japanese pediatric population, is also emerging. CKD prevalence in Asia ranges from 7.0% to 34.3%, with an estimated 434.3 million adults affected, including 65.6 million with advanced CKD according to the National Institutes of Health (NIH). China has the most people with Parkinson disease (PD) in the world and is estimated to have over half of the worldwide PD population. The objective of this study was to analyze the corresponding burden of PD in China for the past decades.
0 · Reply
Futurision
Futurision Jul. 16 at 10:38 PM
My portfolio share as of yesterday was $SRPT 30% $SGMO 30% $OMER 15% $ACHV 15% $NTLA 10% So congrats to all of us and on a a continued ride like this 🚀 Major $SGMO jump next when Fabry Deal is announced
3 · Reply
Rjsmall
Rjsmall Jul. 16 at 6:55 PM
$OMER hey guys is it thursday yet?
3 · Reply
SteadyasSheGoes
SteadyasSheGoes Jul. 16 at 4:45 PM
$OMER Best spin I can come up with is GD knew the SP was going to get to 4 and that is when he started using the ATM again. It is good if he got closer to 4 verses 3 per share. Just does not feel very good at the moment! Add in max pain is $3 Friday and the resulting bleed down Hopefully starting next week we can get back to a nice orderly climb back to 4 and beyond.
1 · Reply
CeloBob
CeloBob Jul. 16 at 3:54 PM
$OMER Parkinson’s disease A friend and long time OMER investor is now in a care facility because his disease has evolved into Parkinson’s dementia. What got my attention was seeing there is a relationship between Parkinson's disease (PD) and its association with endothelial dysfunction .Has Omeros done any research on Parkinson’s?
1 · Reply
LeaLeb
LeaLeb Jul. 16 at 3:39 PM
$OMER ATM hard at work... we going back to where we came from!
1 · Reply
MinnieSteve3
MinnieSteve3 Jul. 16 at 3:29 PM
$OMER Granted there are cash and dilution issues, but it's amazing how this stock gets jerked around so badly so close to the Narso PDUFA date.
1 · Reply
Stocksfirst
Stocksfirst Jul. 16 at 2:44 AM
$OMER - touched $4 and immediately fell back! Not a good sign.
1 · Reply
naturegirl669
naturegirl669 Jul. 16 at 2:26 AM
$OMER - Parkinsons disease----Endothelial injury, particularly in the blood-brain barrier, is increasingly recognized as a potential contributor to Parkinson's disease (PD). This injury can manifest as impaired endothelial function, disrupted blood-brain barrier permeability, and altered vascular structure, potentially impacting disease progression and symptom severity. Impaired Endothelial Function: Studies show decreased flow-mediated dilation (FMD) in PD patients, indicating impaired endothelial function. This can be linked to various factors, including mitochondrial dysfunction, oxidative stress, and traditional cardiovascular risk factors.
0 · Reply
robertward
robertward Jul. 16 at 1:22 AM
$OMER Finally done buying “Omer opportunities” 100k shares! I’m either raving mad or a freakn genius 🤪 Time will tell 🙏
6 · Reply
Latest News on OMER
Omeros Corporation Reports First Quarter 2025 Financial Results

May 15, 2025, 4:05 PM EDT - 2 months ago

Omeros Corporation Reports First Quarter 2025 Financial Results


Omeros' New Leukemia Drug Team Ignites Hope For Cancer Fight

Apr 11, 2025, 3:06 PM EDT - 3 months ago

Omeros' New Leukemia Drug Team Ignites Hope For Cancer Fight


Omeros Corporation (OMER) Q4 2024 Earnings Call Transcript

Mar 31, 2025, 8:57 PM EDT - 3 months ago

Omeros Corporation (OMER) Q4 2024 Earnings Call Transcript


Omeros Corporation (OMER) Q3 2024 Earnings Call Transcript

Nov 13, 2024, 10:22 PM EST - 8 months ago

Omeros Corporation (OMER) Q3 2024 Earnings Call Transcript


Omeros Corporation Reports Third Quarter 2024 Financial Results

Nov 13, 2024, 4:02 PM EST - 8 months ago

Omeros Corporation Reports Third Quarter 2024 Financial Results


Omeros Corporation (OMER) Q2 2024 Earnings Call Transcript

Aug 10, 2024, 1:05 AM EDT - 1 year ago

Omeros Corporation (OMER) Q2 2024 Earnings Call Transcript


Omeros Corporation (OMER) Q1 2024 Earnings Call Transcript

May 15, 2024, 7:23 PM EDT - 1 year ago

Omeros Corporation (OMER) Q1 2024 Earnings Call Transcript


Omeros Corporation (OMER) Q4 2023 Earnings Call Transcript

Apr 1, 2024, 8:09 PM EDT - 1 year ago

Omeros Corporation (OMER) Q4 2023 Earnings Call Transcript


Omeros: Why It Is Worthwhile To Bet On Narsoplimab

Nov 27, 2023, 1:18 AM EST - 1 year ago

Omeros: Why It Is Worthwhile To Bet On Narsoplimab


Omeros Corporation (OMER) Q3 2023 Earnings Call Transcript

Nov 10, 2023, 10:32 AM EST - 1 year ago

Omeros Corporation (OMER) Q3 2023 Earnings Call Transcript


naturegirl669
naturegirl669 Jul. 17 at 6:11 AM
$OMER - Narsoplimab........what about the Asian market??????........any revs there, how soon??? While information on the Asian population specifically regarding HSCT-TMA is limited, studies suggest they are represented in research cohorts, and some data points to their incidence rates for both confirmed and suspected TMA cases. Research on outcomes in specific Asian subgroups, such as the Japanese pediatric population, is also emerging. CKD prevalence in Asia ranges from 7.0% to 34.3%, with an estimated 434.3 million adults affected, including 65.6 million with advanced CKD according to the National Institutes of Health (NIH). China has the most people with Parkinson disease (PD) in the world and is estimated to have over half of the worldwide PD population. The objective of this study was to analyze the corresponding burden of PD in China for the past decades.
0 · Reply
Futurision
Futurision Jul. 16 at 10:38 PM
My portfolio share as of yesterday was $SRPT 30% $SGMO 30% $OMER 15% $ACHV 15% $NTLA 10% So congrats to all of us and on a a continued ride like this 🚀 Major $SGMO jump next when Fabry Deal is announced
3 · Reply
Rjsmall
Rjsmall Jul. 16 at 6:55 PM
$OMER hey guys is it thursday yet?
3 · Reply
SteadyasSheGoes
SteadyasSheGoes Jul. 16 at 4:45 PM
$OMER Best spin I can come up with is GD knew the SP was going to get to 4 and that is when he started using the ATM again. It is good if he got closer to 4 verses 3 per share. Just does not feel very good at the moment! Add in max pain is $3 Friday and the resulting bleed down Hopefully starting next week we can get back to a nice orderly climb back to 4 and beyond.
1 · Reply
CeloBob
CeloBob Jul. 16 at 3:54 PM
$OMER Parkinson’s disease A friend and long time OMER investor is now in a care facility because his disease has evolved into Parkinson’s dementia. What got my attention was seeing there is a relationship between Parkinson's disease (PD) and its association with endothelial dysfunction .Has Omeros done any research on Parkinson’s?
1 · Reply
LeaLeb
LeaLeb Jul. 16 at 3:39 PM
$OMER ATM hard at work... we going back to where we came from!
1 · Reply
MinnieSteve3
MinnieSteve3 Jul. 16 at 3:29 PM
$OMER Granted there are cash and dilution issues, but it's amazing how this stock gets jerked around so badly so close to the Narso PDUFA date.
1 · Reply
Stocksfirst
Stocksfirst Jul. 16 at 2:44 AM
$OMER - touched $4 and immediately fell back! Not a good sign.
1 · Reply
naturegirl669
naturegirl669 Jul. 16 at 2:26 AM
$OMER - Parkinsons disease----Endothelial injury, particularly in the blood-brain barrier, is increasingly recognized as a potential contributor to Parkinson's disease (PD). This injury can manifest as impaired endothelial function, disrupted blood-brain barrier permeability, and altered vascular structure, potentially impacting disease progression and symptom severity. Impaired Endothelial Function: Studies show decreased flow-mediated dilation (FMD) in PD patients, indicating impaired endothelial function. This can be linked to various factors, including mitochondrial dysfunction, oxidative stress, and traditional cardiovascular risk factors.
0 · Reply
robertward
robertward Jul. 16 at 1:22 AM
$OMER Finally done buying “Omer opportunities” 100k shares! I’m either raving mad or a freakn genius 🤪 Time will tell 🙏
6 · Reply
MinnieSteve3
MinnieSteve3 Jul. 15 at 10:36 PM
$OMER Come on, Dr. Makary, approve Narso. Save lives.
1 · Reply
MinnieSteve3
MinnieSteve3 Jul. 15 at 8:13 PM
$OMER Rough day. Gave back all of yesterday's gains -- and then some.
0 · Reply
WinstonWolfff
WinstonWolfff Jul. 15 at 7:57 PM
$OMER Cash and FDA approval talks….everything else is apparently a short opportunity.
0 · Reply
naturegirl669
naturegirl669 Jul. 15 at 6:46 PM
$OMER - OMER chart today almost duplicating XBI and LABU.
0 · Reply
TRYII
TRYII Jul. 15 at 4:05 PM
$OMER bought more for me, bought more for my son, bought more for my daughters, again, again, again, again, again....
0 · Reply
MinnieSteve3
MinnieSteve3 Jul. 15 at 2:30 PM
$OMER They're walking it straight down today. A lot of red candles.
2 · Reply
izacmann
izacmann Jul. 15 at 1:42 PM
$OMER run run run run
0 · Reply
WinstonWolfff
WinstonWolfff Jul. 15 at 12:16 AM
$OMER Dark pool short volume ratio only 37% today.
1 · Reply
capntrps
capntrps Jul. 15 at 12:01 AM
$OMER well at least there is too much hype surrounding the move up in this stock price.
1 · Reply
Caesar65
Caesar65 Jul. 14 at 8:19 PM
$OMER Love the volume, love going up 7% and closing at high of day. Hoping this strength continues back to 5 and beyond
2 · Reply
LeaLeb
LeaLeb Jul. 14 at 8:18 PM
$OMER 4.30-4.50 is our next resistance level.
2 · Reply
naturegirl669
naturegirl669 Jul. 14 at 7:35 PM
$OMER - i keep adding a little here and there........ Is that okay??
5 · Reply